Serum leucine-rich alpha-2 glycoprotein as a predictive factor of endoscopic remission in Crohn's disease.
Izuru AbeHisashi ShigaHirofumi ChibaTeruko MiyazawaShinya OomoriYusuke ShimoyamaRintaro MoroiMasatake KurohaYoichi KakutaYoshitaka KinouchiAtsushi MasamunePublished in: Journal of gastroenterology and hepatology (2022)
From the early phase of biologic treatment, both FC and LRG had high specificity for predicting ER at week 52. LRG showed higher sensitivity than FC.